JPMORGAN EUROPEAN GROWTH & INCOME PLC (the 'Company') |
|
Legal Entity Identifier: 549300D8SPJFHBDGXS57 |
|
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 30 September 2024 |
|
Novo Nordisk |
5.0% |
Asml |
4.1% |
Sap |
3.6% |
Novartis |
3.3% |
Nestle |
2.8% |
Roche Holdings |
2.8% |
Allianz |
2.5% |
Schneider Electric |
2.5% |
Totalenergies |
2.5% |
JPMorgan European Discovery Trust Plc |
2.2% |
Total |
31.3% |
Excludes Investments in Liquidity stocks |
|
Name of contact and telephone number for queries: |
|
Paul Ainger 0044 207 742 6524 |
|
Name of authorised company official responsible for making this notification: |
|
Paul Winship 0044 207 742 9815 - Company Secretary |
|
Date: 10 October 2024 |
|
|
|